Skip to main content
. 2015 Nov 9;2016:7075682. doi: 10.1155/2016/7075682

Figure 3.

Figure 3

The time course of vasorelaxant effects of testing compounds in aortic rings on the sustained contraction induced by PE. (a) The vasorelaxation time-effect curve of 100 μmol/L SPRC. (b) The vasorelaxation time-effect curve of 100 μmol/L furoxan. (c) The vasorelaxation time-effect curve of 100 μmol/L ZYZ-803. (d) The vasorelaxation time-effect curve of 100 μmol/L furoxan plus 100 μmol/L SPRC. Data represent mean ± SEM, n ≥ 5 for each group.